Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1484671

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1484671

India Skin Care Dermacosmetics Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024-2030)

PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 1800
Printable PDF (Group User License)
USD 2700
Printable PDF (Enterprise License)
USD 4000

Add to Cart

Market Overview

The Indian skin care derma cosmetics market size was 256.2 million in 2023, which is expected to witness a CAGR of 10.3% during the forecast period 2024-2030, to reach 505.0 million in 2030.

The significant factors driving the market growth include the growing emphasis on facial appearance, the online shopping craze, the increasing number of skin diseases, and the teenagers entering adulthood earlier in their lives.

The participation of the partners in the side of Indian skincare derma cosmetics industry is so remarkable that it contributes to a greater number of available products in the market for customers. This collaboration is key to the improvement of the efficacy of products used for a diverse gamut of skin problems.

Additionally, different beauty products from international luxury brands are teaming with Indian e-commerce beauty product retailers to feature these products in India. As an illustration, Curology Inc., a supplier of dermatological and bespoke skincare products, has announced that Amazon will be its e-market partner.

With prolonged UV exposure as well as exposure to pollution, the number of skin-related conditions, such as photoaging, is growing. This causes skin to lose elasticity, get sunburn, and lose hair. Among more reasons, skin diseases could be attributed to different factors, like pollution, excessive alcohol consumption, and cigarette smoking. Hyperpigmentation, psoriasis, and dyspigmentation. Acne, freckles, atopic dermatitis, melasma, and deep wrinkles from the list of popular skin problems are as follows.

Key Insights

In 2023, the skinshine had the largest industry share in the market, with a share of 20%.

This brand's popularity can be credited to its efficiency in treating and avoiding moderate-to-severe melasma, whitening skin tone, and reducing senile lentigines.

Skinshine is popular for its topical formulation comprising 3 main ingredients: tretinoin, mometasone, and hydroquinone.

Cetaphil is projected to witness the fastest development rate of 10.8% over the projection period in the Indian skincare dermacosmetics industry.

In 2023, the acne category had the largest share in the industry because of its extensive appeal across numerous age groups, particularly the young populace.

The occurrence of acne problems and the growing per-capita income among Indian customers contribute to the development of this category.

Indian customers are eager to spend more on skincare items to attain better skin well-being and appearance.

The wrinkles and fine lines application category is projected to witness substantial development, propelled by heightened awareness among Generation X and Generation Y regarding aging-associated skin concerns.

There is a growing trend of spending on skincare treatments and products aimed at reducing signs of aging and enhancing overall appearance among Indian consumers.

There is a paradigm shift in the Indian cosmetics market towards skin care treatments and products mainly aimed at removing wrinkles and improving appearance.

The northern region was the dominant force in the Indian skincare derma cosmetics market in 2023 due to the increasing prevalence of skin diseases and the improved healthcare infrastructure.

Western area is anticipated to have the highest compound annual Growth Rate (CAGR) of 10.6% within the forecast period. This growth is fuelled by increased personalized skincare usage and growing attention towards sophisticated derma cosmetic products.

In southern India, Hyderabad, Bengaluru, and Chennai are the cities that have a developed healthcare infrastructure and a large population that is much aware of skin diseases as well as international skincare brands.

Product Code: 12114

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by brand
    • 1.4.2. Market size breakdown, by application
    • 1.4.3. Market size breakdown, by region
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. India Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Brand (2017-2030)
  • 6.3. Market Revenue, by Application (2017-2030)

Chapter 7. Competitive Landscape

  • 7.1. List of Market Players and their Offerings
  • 7.2. Competitive Benchmarking of Key Players
  • 7.3. Product Benchmarking of Key Players
  • 7.4. Recent Strategic Developments

Chapter 8. Company Profiles

  • 8.1. Emami Group
    • 8.1.1. Business overview
    • 8.1.2. Product and service offerings
    • 8.1.3. Key financial summary
  • 8.2. Cadila Pharmaceuticals Limited
    • 8.2.1. Business overview
    • 8.2.2. Product and service offerings
    • 8.2.3. Key financial summary
  • 8.3. HEGDE & HEGDE PHARMACEUTICA LLP
    • 8.3.1. Business overview
    • 8.3.2. Product and service offerings
    • 8.3.3. Key financial summary
  • 8.4. Piramal Enterprises Limited
    • 8.4.1. Business overview
    • 8.4.2. Product and service offerings
    • 8.4.3. Key financial summary
  • 8.5. Honasa Consumer Limited
    • 8.5.1. Business overview
    • 8.5.2. Product and service offerings
    • 8.5.3. Key financial summary
  • 8.6. Torrent Pharmaceuticals Ltd.
    • 8.6.1. Business overview
    • 8.6.2. Product and service offerings
    • 8.6.3. Key financial summary
  • 8.7. Galderma S.A.
    • 8.7.1. Business overview
    • 8.7.2. Product and service offerings
    • 8.7.3. Key financial summary
  • 8.8. Johnson & Johnson Services Inc.
    • 8.8.1. Business overview
    • 8.8.2. Product and service offerings
    • 8.8.3. Key financial summary
  • 8.9. NAOS
    • 8.9.1. Business overview
    • 8.9.2. Product and service offerings
    • 8.9.3. Key financial summary
  • 8.10. Sebapharma GmbH & Co. KG
    • 8.10.1. Business overview
    • 8.10.2. Product and service offerings
    • 8.10.3. Key financial summary
  • 8.11. NYKAA E-RETAIL LIMITED
    • 8.11.1. Business overview
    • 8.11.2. Product and service offerings
    • 8.11.3. Key financial summary

Chapter 9. Appendix

  • 9.1. Abbreviations
  • 9.2. Sources and References
  • 9.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!